DEFERASIROX VISO FARMACEUTICA
As listed in the register: DEFERASIROX VISO FARMACEUTICA 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
360 mg · comprimido recubierto con película
- Prescription only
- Everything that fits nowhere else, such as contrast media
- Active substance
- Deferasirox
- Made by
- Glenmark Arzneimittel Gmbh
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Exjade). It describes the substance, not this exact product.
Exjade (deferasirox) is an orally active chelator that is selective for iron (as Fe 3+ ).
It is a tridentate ligand that binds iron with high affinity in a 2:1 ratio.
Deferasirox and metabolites are primarily (84% of the dose) excreted in the feces.
The bioavailability (AUC) of deferasirox was variably increased when taken with a meal.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-01-28
Safety of the active substance
From the US prescribing label for the same active substance (Exjade). It describes the substance, not this exact product.
WARNING: RENAL FAILURE, HEPATIC FAILURE, and GASTROINTESTINAL HEMORRHAGE Renal Failure Exjade can cause acute renal failure and death, particularly in patients with comorbidities and those who are in the advanced stages of their hematologic disorders.
- Estimated GFR less than 40 mL/min/1.73 m 2.
- ( 4 ) Patients with poor performance status.
- ( 4 ) Patients with high-risk myelodysplastic syndrome (MDS).
- ( 4 ) Patients with advanced malignancies.
The most frequently occurring (greater than 5%) adverse reactions are diarrhea, rash, and nausea.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States14 matching products
European UnionNo exact match for this strength and form
Canada9 matching products
- ALEMBIC-DEFERASIROX (TYPE J) 360 mg · tablet
- APO-DEFERASIROX (TYPE J) 360 mg · tablet
- AURO-DEFERASIROX (TYPE J) 360 mg · tablet
- DEFERASIROX (TYPE J) 360 mg · tablet
- JADENU 360 mg · tablet
- JAMP DEFERASIROX (TYPE J) 360 mg · tablet
- PMS-DEFERASIROX (TYPE J) 360 mg · tablet
- SANDOZ DEFERASIROX (TYPE J) 360 mg · tablet
Netherlands22 matching products
- Deferasirox Teva 360 mg 360 mg · filmomhulde tablet2 makers
- Deferasirox Abdi 360 mg filmomhulde tabletten 360 mg · filmomhulde tablet
- Deferasirox Accord 360 mg 360 mg · filmomhulde tablet
- Deferasirox Amarox 360 mg filmomhulde tabletten 360 mg · filmomhulde tablet
- Deferasirox Aurobindo 360 mg 360 mg · filmomhulde tablet
- Deferasirox betapharm 360 mg 360 mg · filmomhulde tablet
- Deferasirox DOC 360 mg 360 mg · filmomhulde tablet
- Deferasirox MSN 360 mg filmomhulde tabletten 360 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Glenmark Arzneimittel Gmbh |
|---|---|
| Active substance | Deferasirox |
| Used in | Everything that fits nowhere else, such as contrast media |
| Strength | 360 mg |
| Form | comprimido recubierto con película |
| Classification | V03AC03 · Everything that fits nowhere else, such as contrast media |
| Route | vía oral |
| Marketed | Yes, according to the register |
| Generic | Yes — a generic medicine, according to the register |
| Name in the register | DEFERASIROX VISO FARMACEUTICA 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG |
| Nº Registro | 86445 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- comprimido recubierto con película2 products
- 90 mg
- 360 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.